Document is current
Any future updates will be listed below
-
Authors
Feldman, David
Tsai, FuNien
Garrity, Anthony J.
O’Rourke, Ryan
Brenan, Lisa
Ho, Patricia
Gonzalez, Elizabeth
Konermann, Silvana
Johannessen, Cory M.
Beroukhim, Rameen
Bandopadhayay, Pratiti
Blainey, Paul C.
-
Funding
Funding for this research was provided by:
National Institutes of Health (CA201592-02, 1U54CA224068-01, CA188228, CA219943, HG009283)
SPARC funding from the Broad Institute
Koch Foundation
Dana-Farber Cancer Institute
St. Baldrick's Foundation
Pediatric Brain Tumor Foundation
Alex's Lemonade Stand Foundation for Childhood Cancer
Jared Branfman Sunflowers for Life Fund for Pediatric Brain and Spinal Cancer Research
Burroughs Wellcome Fund
- License Information
-
More Information
Article History
Received: 30 August 2020
Accepted: 28 October 2020
First Online: 24 November 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: R.B. and P.B. receive grant funding from the Novartis Institute of Biomedical Research for an unrelated project. C.M.J. is currently a full-time employee and stockholder of Novartis Institutes of BioMedical Research, Inc. P.C.B. consults broadly in the biotechnology industry on topics not directly related to this work. The Broad Institute, Dana-Farber Cancer Institute, and MIT may seek to commercialize aspects of this work, and related applications for intellectual property have been filed. PB serves as a consultant for QED Therapeutics for unrelated work. F.T. is currently a full-time employee and shareholder of 10x Genomics.
